Flávio Cadegiani
Flávio Cadegiani is a Brazilian physician and researcher known for his involvement in studies related to proxalutamida, a drug that has not been approved for use in Brazil or other countries. During the COVID-19 pandemic, he was linked to irregular research practices concerning the drug's use against the virus, leading to investigations by the authorities. Cadegiani has maintained that he never advised the use of the drug outside of clinical research settings.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Liechtenstein | 1 | 2.00 | 0.09% | +0% | 38,137 | 36 | $6,900 | 6$ |
| Totals | 1 | 38,137 | 36 | $6,900 | 6$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
Flávio Cadegiani was the doctor leading the irregular research on the prohibited medication.
2